Surgery and Wegovy: what you need to tell your surgical team

Step 1, Tell your surgical team before you book, not on the day

The conversation needs to happen early. Once a procedure is scheduled, your anaesthetist will ask about all regular medicines; Wegovy should be on that list from the start. The reason is pharmacological rather than bureaucratic. Semaglutide acts on GLP-1 receptors in the gut, slowing how quickly food and liquid move through the stomach. That delay can persist even after a normal nil-by-mouth period, meaning there is a genuine risk of undigested stomach contents being present during general or sedation anaesthesia. Whether surgery is safe while on Wegovy is a question our prescribers are asked regularly, and the honest answer is that it depends on timing, the kind of operation, and the team's individual assessment.

NHS England guidance is clear on this point: anyone taking a GLP-1 medicine should inform their healthcare team, including the anaesthetist, before any surgical procedure. That instruction applies regardless of the dose you are on or how long you have been taking it. Do not wait for the pre-operative assessment appointment, mention it when you first discuss the operation.

One quick checking habit worth building: look at your Wegovy pen's label and note the dose and injection date, then share that exact information with your surgical team. It takes under a minute and gives your anaesthetist the detail they need to plan your fasting protocol accurately.

Step 2, Discuss stopping Wegovy before the operation

Most anaesthetic teams will ask you to pause Wegovy for a defined period ahead of your procedure. The duration varies. It depends on your dose, the nature of the surgery, whether it involves the gastrointestinal tract, and local anaesthetic protocols, none of which are standardised uniformly across the UK. Because of this, there is no single universally agreed pause period that applies to every patient. Stopping Wegovy for surgery is a decision your prescriber and surgical team should make jointly, taking your individual circumstances into account.

What is known is that semaglutide's half-life is approximately one week, which means its effects on gastric emptying can persist for some time after the last injection. Your surgical team may therefore ask for a pause longer than you might expect. Follow their guidance precisely. If you have concerns about weight regain during a break, raise them with your prescriber, that is a legitimate clinical conversation, and the answer will differ depending on how long you have been on treatment and how stable your weight is.

Do not stop and restart without telling someone. An unplanned gap followed by an unannounced restart can create gaps in clinical oversight. Taking Wegovy immediately before surgery is something to actively avoid unless your team has specifically said otherwise. The Patient Information Leaflet, available via the Medicines Compendium (eMC), also covers what to do if doses are delayed or missed in broader circumstances.

Step 3, Restarting Wegovy after surgery

Recovery changes the picture in several ways. Your appetite, gut motility and nutritional needs after an operation are all different from your pre-surgery baseline. Reintroducing a medicine that suppresses appetite and slows gastric emptying into that context needs care. Your surgical team or GP should give you a clear green light before you resume, and your prescriber at any pharmacy (including ours) will want confirmation that you are medically ready before supplying the next pen.

For people who have had bariatric surgery specifically, the considerations are more complex still. Using Wegovy after bariatric surgery raises questions about absorption, nutritional adequacy and whether the appetite-suppression effects interact with the dietary restrictions that bariatric procedures impose. This is a specialist conversation, not one to navigate based on general guidance alone.

Once you have recovered and your clinical team is satisfied, resuming Wegovy is typically straightforward. You may need to restart at a lower dose if a significant break has occurred, again, a prescriber decides that, not the patient. If you are ready to pick up where you left off, speaking to our prescribers is the right starting point: they review every repeat order individually rather than dispensing automatically, which means a post-surgery restart receives the clinical attention it warrants.

What is still uncertain, and who to talk to

The evidence base around GLP-1 medicines and anaesthesia is still developing. Professional anaesthetic bodies across the UK and internationally have issued varying guidance, and local hospital protocols are not uniform. What is settled is that the risk is real and manageable with proper planning; what varies is the exact fasting extension or pause duration your team recommends. NHS England's guidance on weight-management injections confirms the obligation to disclose, while leaving the specific protocol to the treating clinicians.

If you are pregnant, trying to conceive, or breastfeeding, Wegovy is not recommended regardless of any surgical context, speak to your GP, and see our guidance on Wegovy and pregnancy for the full picture. For those with cardiovascular conditions, the interaction between surgery, Wegovy and cardiac risk is another reason to ensure your whole team is aware; our page on Wegovy and heart health covers the cardiovascular evidence. If you have questions our prescribers have not yet answered, our support team is available seven days a week.